BUSPAR
BUSPIRONE HYDROCHLORIDE
Approval overview BUSPAR is listed in Drugs@FDA under application 021190 (NDA).
Review priority: STANDARD Marketing status: Discontinued Active ingredient BUSPIRONE HYDROCHLORIDE Form and strength CAPSULE;ORAL - 10MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** Sponsor BRISTOL MYERS SQUIBB Submission history Latest submission status date: 2000-12-20 00:00:00.
Structured Monograph
Clinical summary
Approval overview BUSPAR is listed in Drugs@FDA under application 021190 (NDA). Review priority: STANDARD Marketing status: Discontinued Active ingredient BUSPIRONE HYDROCHLORIDE Form and strength CAPSULE;ORAL - 10MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** Sponsor BRISTOL MYERS SQUIBB Submission history Latest submission status date: 2000-12-20 00:00:00. Submission type: ORIG.
Monitoring
- • Marketing status: Discontinued
- • Review priority: STANDARD
Interaction Notes
- No interaction notes stored yet.